Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Inhibrx, Inc.”

28 pharma patents match "Inhibrx, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 28
Index total 30,257
Page 2 / 2

Quick answer

This filtered view shows 28 pharmaceutical patents matching "Inhibrx, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

28 results for “Inhibrx, Inc.” · 30,257 patents in full index Clear search

  1. US 9663575

    CD47 antibodies and methods of use thereof

    Inhibrx, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted

  2. US 9045541

    CD47 antibodies and methods of use thereof

    Inhibrx, Inc. · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  3. US 8986688

    WAP domain fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  4. US 8980266

    Serpin fusion polypeptides and methods of use thereof

    Inhibrx, Inc. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.